| Overall | CI-AKI |  | P value |
---|---|---|---|---|
Characteristics | (n = 4386) | No (n = 3599) | Yes (n = 787) |  |
Demographic features | Â | Â | Â | Â |
Age, years old | 67.1 ± 10.8 | 66.6 ± 10.7 | 69.4 ± 10.7 | < 0.001* |
Male, n (%) | 2895 (66.0) | 2422 (67.3) | 473 (60.1) | < 0.001* |
Diabetes, n (%) | 1058 (24.1) | 836 (23.2) | 222 (28.2) | 0.004* |
Prior PCI, n (%) | 1088 (24.8) | 920 (25.6) | 168 (21.3) | 0.013* |
Prior MI, n (%) | 340 (7.8) | 283 (7.9) | 57 (7.2) | 0.555 |
LVEF, % | 59.7 ± 13.0 | 60.4 ± 12.9 | 56.6 ± 13.3 | < 0.001* |
Average SBP, mmHg | 123.2 ± 14.4 | 123.8 ± 14.1 | 120.6 ± 15.5 | < 0.001* |
Nutritional status | Â | Â | Â | Â |
NRS-2002 score | 1.0 [0.0, 1.0] | 1.0 [0.0, 1.0] | 1.0 [1.0, 2.0] | < 0.001* |
CONUT score | 3.0 [1.0, 4.0] | 3.0 [1.0, 4.0] | 3.0 [2.0, 5.0] | < 0.001* |
PNI score | 45.8 [41.7, 49.7] | 46.32 [42.5, 50.1] | 43.5 [38.0, 48.2] | < 0.001* |
GNRI score | 98.6 [92.6, 103.3] | 99.0 [93.5, 103.6] | 95.9 [88.4, 101.7] | < 0.001* |
Laboratory data | Â | Â | Â | Â |
Scr on admission, μmol/L | 76.0 [64.0, 94.0] | 76.0 [65.0, 93.0] | 73.0 [60.0, 100.0] | 0.090* |
Scr elevation, % | 5.2 [−3.9, 18.2] | 1.9 [−5.7, 10.1] | 43.2 [32.4, 68.1] | < 0.001* |
eGFR, ml/min/1.73m2 | 78.7 ± 23.3 | 79.4 ± 22.1 | 75.6 ± 28.0 | 0.012* |
Total cholesterol, mmol/L | 4.09 ± 1.19 | 4.12 ± 1.18 | 3.99 ± 1.21 | 0.006* |
Low density lipoprotein, mmol/L | 2.22 ± 0.91 | 2.22 ± 0.91 | 2.20 ± 0.89 | 0.485 |
C-reactive protein, mg/L | 2.3 [0.9, 8.0] | 2.0 [0.8, 6.6] | 4.4 [1.5, 16.0] | < 0.001* |
Hemoglobin, g/L | 128.1 ± 19.9 | 129.8 ± 18.9 | 120.6 ± 22.1 | < 0.001* |
Lymphocyte, × 109/L | 1.39 ± 0.60 | 1.41 ± 0.58 | 1.31 ± 0.67 | < 0.001* |
Serum albumin, g/L | 38.6 ± 5.0 | 39.1 ± 4.7 | 36.6 ± 5.7 | < 0.001* |
CAG/PCI data | Â | Â | Â | Â |
CAG with PCI, n (%) | 1993 (45.4) | 1626 (45.2) | 367 (46.6) | 0.482 |
Volume of contrast agent, mg | 80.0 [50.0, 130.0] | 80.0 [50.0, 130.0] | 80.0 [52.0, 140.0] | 0.249 |
Type of contrast agent, n (%) | Â | Â | Â | 0.992 |
Isotonic | 1387 (31.6) | 1138 (31.6) | 249 (31.6) | Â |
Hypotonic | 2999 (68.4) | 2461 (68.4) | 538 (68.4) | Â |
Chronic total occlusion, n (%) | 711 (16.2) | 579 (16.1) | 132 (16.8) | 0.637 |
Total length of stents, mm | 38.0 [25.0, 63.0] | 39.0 [25.0, 64.0] | 36.0 [24.0, 57.0] | 0.101 |
Pre-procedure medication, n (%) | Â | Â | Â | Â |
Statin | 3655 (83.3) | 3052 (84.8) | 603 (76.6) | < 0.001* |
Aspirin | 3632 (82.8) | 3061 (85.1) | 571 (72.6) | < 0.001* |
Oral furosemide | 1266 (28.9) | 899 (25.0) | 367 (46.6) | < 0.001* |
Furosemide injection | 660 (15.0) | 421 (11.7) | 239 (30.4) | < 0.001* |
Dopamine | 1231 (28.1) | 929 (25.8) | 302 (38.4) | < 0.001* |